Detalhe da pesquisa
1.
Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework.
Value Health
; 27(4): 433-440, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38191022
2.
Tackling Challenges in Assessing the Economic Value of Tumor-Agnostic Therapies: A Cost-Effectiveness Analysis of Pembrolizumab as a Case Study.
Value Health
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38548177
3.
How Much Does the US Public Value Equity in Health? A Systematic Review.
Value Health
; 26(3): 418-426, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36216706
4.
Real-world treatment patterns and economic burden of post-cataract macular edema.
BMC Ophthalmol
; 23(1): 380, 2023 Sep 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37723463
5.
Does Clinical Evidence of Heterogeneity Impact Treatment Selection? A Case Study of Abiraterone for Metastatic Prostate Cancer.
J Natl Compr Canc Netw
; 20(10): 1107-1115.e12, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240855
6.
Assessing Payers' Preferences for Real-World Evidence in the United States: A Discrete Choice Experiment.
Value Health
; 25(3): 443-450, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35227457
7.
Key learnings from Institute for Clinical and Economic Review's real-world evidence reassessment pilot.
Int J Technol Assess Health Care
; 38(1): e32, 2022 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35357284
8.
Cost-effectiveness analysis of low-dose direct oral anticoagulant (DOAC) for the prevention of cancer-associated thrombosis in the United States.
Cancer
; 126(8): 1736-1748, 2020 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31999844
9.
Alternative Approaches to Quality-Adjusted Life-Year Estimation Within Standard Cost-Effectiveness Models: Literature Review, Feasibility Assessment, and Impact Evaluation.
Value Health
; 23(12): 1523-1533, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33248507
10.
Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy.
Value Health
; 22(9): 988-994, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511188
11.
Defining and Managing High-Priced Cures: Healthcare Payers' Opinions.
Value Health
; 22(6): 648-655, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31198181
12.
The Cost-Effectiveness of Financial Incentives for Viral Suppression: HPTN 065 Study.
Value Health
; 22(2): 194-202, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30711064
13.
Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer.
Oncologist
; 20(12): 1355-64, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26482553
14.
Economic evaluation of tocilizumab monotherapy compared to adalimumab monotherapy in the treatment of severe active rheumatoid arthritis.
Value Health
; 18(2): 173-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25773552
15.
Cost-effectiveness of a 14-gene risk score assay to target adjuvant chemotherapy in early stage non-squamous non-small cell lung cancer.
Oncologist
; 19(5): 466-76, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24710309
16.
How can clinical researchers quantify the value of their proposed comparative research?
Am Heart J
; 209: 116-125, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30638543
17.
Virtual versus usual in-office care for multiple sclerosis: The VIRTUAL-MS multi-site randomized clinical trial study protocol.
Contemp Clin Trials
; 142: 107544, 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38657731
18.
The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis.
Breast Cancer Res Treat
; 141(1): 13-22, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23974828
19.
Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer genomics research.
Genet Med
; 15(2): 115-22, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23037935
20.
How does cumulative evidence from older adult-specific trials influence clinical practice? A difference-in-differences analysis in early-stage breast cancer.
Contemp Clin Trials
; 128: 107135, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868347